Sort by
Refine Your Search
-
, and scholarly activities. In partnership with Northeastern University, Dompé is offering a two-year fellowship in Global Medical Affairs - Real-World Evidence & Health Economics and Outcomes Research
-
partner in the business. Responsibilities Are you passionate about science and experienced within regulatory affairs and drug development? Do you possess strategic and operational leadership skills? Then
-
Alnylam We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA
-
are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered
-
who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug
-
Alnylam We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has
-
, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Cambridge, MA
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Clinical Science fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA